Medicamen Organics (NSE:MEDIORG) Operating Margin %: -160.37% (As of Mar. 2026)


NSE:MEDIORG Medicamen Organics Ltd NSE:MEDIORG
21 GF Score
Price ₹24.20
! 11 Warning Signs
View Full Analysis

What is Medicamen Organics Operating Margin %?

Medicamen Organics NSE:MEDIORG -2.81% 21 Operating Margin % is -160.37% as of Mar. 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 21/100. The stock has 11 warning signs investors should review. Among 953 Drug Manufacturers companies, Medicamen Organics ranks worse than 93.28% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Medicamen Organics's Operating Income for the six months ended in Mar. 2026 was ₹-76.63 Mil. Medicamen Organics's Revenue for the six months ended in Mar. 2026 was ₹47.78 Mil. Therefore, Medicamen Organics's Operating Margin % for the quarter that ended in Mar. 2026 was -160.37%.

The historical rank and industry rank for Medicamen Organics's Operating Margin % or its related term are showing as below:

NSE:MEDIORG' s Operating Margin % Range Over the Past 10 Years
Min: -160.37   Med: 5.28   Max: 16.3
Current: -160.37


NSE:MEDIORG's Operating Margin % is ranked worse than
93.28% of 953 companies
in the Drug Manufacturers industry
Industry Median: 7.59 vs NSE:MEDIORG: -160.37

Medicamen Organics's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Medicamen Organics's Operating Income for the six months ended in Mar. 2026 was ₹-76.63 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-76.63 Mil.

Warning Sign:

Medicamen Organics Ltd has recorded a loss in operating income at least once over the past 3 years.


Medicamen Organics  (NSE:MEDIORG) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Medicamen Organics Operating Margin % Related Terms


Medicamen Organics Operating Margin % Historical Data

* Premium members only.

The historical data trend for Medicamen Organics's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics Operating Margin % Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
Get a 7-Day Free Trial 2.47 5.33 16.30 15.32 -20.54

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Mar25 Mar26
Operating Margin % Get a 7-Day Free Trial 0.00 18.19 14.77 16.13 -160.37

NSE:MEDIORG vs ZTS, UTHR: Operating Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicamen Organics Operating Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Medicamen Organics's Operating Margin % falls into.


NSE:MEDIORG
21GF Score
Medicamen Organics Ltd NSE:MEDIORG
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Organics Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Medicamen Organics's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=-46.478 / 226.303
=-20.54 %

Medicamen Organics's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-76.626 / 47.78
=-160.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -160.37% mean?
Medicamen Organics (NSE:MEDIORG) has a Operating Margin % of -160.37% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Medicamen Organics and its competitors. According to the industry distribution chart, Medicamen Organics ranks #889 out of 953 companies in the Drug Manufacturers industry, placing it in the top 93.3%.
Is Medicamen Organics' Operating Margin % too high?
Medicamen Organics' current Operating Margin % is -160.37%. Based on the distribution chart, Medicamen Organics ranks #889 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicamen Organics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medicamen Organics ranks #889 out of 953 companies for Operating Margin %. This places Medicamen Organics in the lower half of its industry. The industry median Operating Margin % is 7.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.59, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Medicamen Organics and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicamen Organics's current Operating Margin % is -160.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current Operating Margin % of -160.37%. The current Operating Margin % is -160.37%. Medicamen Organics' overall GF Score™ is 21/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current Operating Margin % is -160.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicamen Organics Business Description

Address Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
21GF Score

Get the complete analysis for NSE:MEDIORG

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹24.20
Price